GeneDx is trading at $69.99 (6.46% up) as the stock appears to be rebounding from recent volatility, despite a lack of new company-specific announcements.
- The upward move follows a strong premarket session, though no major sector-wide drivers have been identified to explain the price action.
- Broader market sentiment remains mixed as the equity recovers ground following a period of recent price fluctuations.